Empowering Oncology Decisions
DiagnoCure is a life sciences company that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions.
2013 Annual General and Special Meeting of Shareholders
- May 16, 2013 - DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO annual meeting
- April 29, 2013 - DiagnoCure Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders